Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27c4aecf8dd5e18bac90e5be827574cf |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
filingDate |
2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c0591955c2f13772fadc460972473b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ea25f32ed2505bca54c8d0f8840ef2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74997d11d78bfae303323f529a0719b5 |
publicationDate |
2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11077116-B2 |
titleOfInvention |
Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients |
abstract |
The invention refers to the use of isoxazole derivatives to prepare medicament able to induce fetal hemoglobin (HbF) synthesis in β-thalassemia and sickle cell disease (SCD) patients. |
priorityDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |